This technical note discusses the methods and factors, investment bankers and venture capitalists to take into account when placing value on the shares of biotechnology companies. "Hide
by James E. Hatch 12 pages. Publication Date: February 15, 2008. Prod. #: 908N05-PDF-ENG
Related Case Solutions & Analyses:
Bright and Dedicated: What More Do You Want
Note on Central Planning
Higher-Education Harvest
The Real Green IT Machine (B): Sensitivity Analysis of a Proposed Capital Investment
High-Speed Rail in Portugal
Triple Point Technology
Dogloo and Opportunity Capital Partners
Pension Policy at the Boots Co. PLC
Valuation on “Plain Vanilla” Interest-Rate Swaps
Wells Fargo Online Financial Services (A), Spanish Version
